Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aleafia Health Inc ALEAF

Aleafia Health Inc. is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets. The Company is engaged in the production, sale, and distribution of cannabis. It operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada. The Company operates two licensed cannabis production facilities and operates a strategically located distribution center all in the province of Ontario, including the largest, outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips and topicals. It markets and sells cannabis products through regulated intermediaries into selected international markets, tactically sells cannabis products into Canadian wholesale markets.


GREY:ALEAF - Post by User

Post by sthineion Nov 03, 2021 8:57am
190 Views
Post# 34081218

Hexo is going to have to announce some cuts in order to

Hexo is going to have to announce some cuts in order to
survive.  THey need to significantly cut capex.  It is a situation pretty much industry wide in Canada.  Tilray dong OK because they have such a strong position internationally and in medical market.   It is aleafs saving grace that they do not have ridiculous amounts of debt.  Issue is they need to ramp up sales and not sales at .48/gram as they did last year. 
If they could announce an expansion of their parnership with Bullridr into the recreatonal market and be the deicated supplier that would be a good headline,  then couple that with EU GMP certification they will be on their way.   On their way to line themselves up for a sale at maybe $300 million debt included.  So maybe $240 million for the outstanding shares.  Perhaps .75 Cdn.  I think to expect much more than that is dreaming.
<< Previous
Bullboard Posts
Next >>